| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/04/2006 | EP1707578A2 Preparation of low molecular weight hyaluronic acid as a food supplement |
| 10/04/2006 | EP1707572A2 Sterol compositions from pulping soap |
| 10/04/2006 | EP1707571A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 10/04/2006 | EP1707568A2 A pharmaceutical composition for use in the treatment of ovarian cancer in a human afflicted therewith |
| 10/04/2006 | EP1707567A1 Novel fused-ring compound |
| 10/04/2006 | EP1707566A1 Deazapurines and uses thereof |
| 10/04/2006 | EP1707565A1 Losartan potassium crystalline form alpha |
| 10/04/2006 | EP1707564A2 Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 10/04/2006 | EP1707563A2 Methods and compositions utilizing quinazolinones |
| 10/04/2006 | EP1707562A1 Crystalline form gamma of the chlorhydrate of ivabradine, process for its preparation and pharamcetuical composition containing it |
| 10/04/2006 | EP1707560A1 Hydroxamic acid derivative and age generation inhibitor containing the derivative |
| 10/04/2006 | EP1707558A1 Benzoic acid ester compounds, compositions, uses and methods related thereto |
| 10/04/2006 | EP1707217A1 Process for preparing an alpha lipoic acid/cyclodextrin complex and product prepared |
| 10/04/2006 | EP1707216A1 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 10/04/2006 | EP1707214A1 Antagonists of HMG1 for treating inflammatory conditions and the use of HMG1 for effecting weightloss or treating obesity |
| 10/04/2006 | EP1707211A1 Ceramidase inhibitor |
| 10/04/2006 | EP1707208A1 Blood flow promoters for cauda equina tissues |
| 10/04/2006 | EP1707207A2 Use of a food additive comprising theobromine for the prevention of colon, gastric or liver cancer |
| 10/04/2006 | EP1707206A1 Piperazine derivates for the inhibition of beta-secretase, cathepsin D, plasmepsin ll and HIV protease and for the treatment of malaria, Alzeheimer and AIDS |
| 10/04/2006 | EP1707205A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 10/04/2006 | EP1707204A1 Treatment of epilepsy with non-imidazole alkylamines histamine H3-receptor ligands |
| 10/04/2006 | EP1707203A1 Treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3- receptor ligands |
| 10/04/2006 | EP1707202A1 Organic compounds |
| 10/04/2006 | EP1707201A1 Oxaprozin or a closely related compound for the treatment of eczema |
| 10/04/2006 | EP1707200A1 Dermatological compositions comprising oxaprozin or a closely related compound for the treatment of dermatological diseases |
| 10/04/2006 | EP1707199A1 Oxaprozin or closely related compound for the treatment and prevention of pruritus |
| 10/04/2006 | EP1707198A1 Preventive or ameliorating agent for liver disease involving hepatopathy |
| 10/04/2006 | EP1707197A1 Formulations containing fenofibrate and a surfactant mixture |
| 10/04/2006 | EP1707196A1 Improved formulations of fenofibrate |
| 10/04/2006 | EP1707195A1 Retinoic acid-containing remedy for diabetes |
| 10/04/2006 | EP1707194A1 Stress relieving composition |
| 10/04/2006 | EP1707193A2 Pharmaceutical composition for the prophylaxis and/or treatment of viral diseases |
| 10/04/2006 | EP1707061A2 Process for the heterotrophic production of microbial products with high concentration of omega-3 highly unsaturated fatty acids |
| 10/04/2006 | EP1706511A2 Compositions and methods for generating short double-stranded rna using mutated rnase iii |
| 10/04/2006 | EP1706492A2 Materials and methods relating to cell cycle control |
| 10/04/2006 | EP1706489A1 Oligomeric compounds for the modulation of bcl-2 |
| 10/04/2006 | EP1706415A1 Lipid- derivatized bisphosphonic acid |
| 10/04/2006 | EP1706413A1 Tricyclic benzazepine derivatives as squalene synthase inhibitors used for the treatment of cardiovascular diseases |
| 10/04/2006 | EP1706412A1 Novel pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same |
| 10/04/2006 | EP1706409A1 Compounds useful in therapy |
| 10/04/2006 | EP1706407A2 Novel crystalline forms of temozolomide |
| 10/04/2006 | EP1706405A1 4'-substituted carbovir- and abacavir-derivatives as well as related compounds with hiv and hcv antiviral activity |
| 10/04/2006 | EP1706404A2 Tetrahydrocarboline compounds as anticancer agents |
| 10/04/2006 | EP1706403A2 Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment |
| 10/04/2006 | EP1706402A1 Cathepsin cysteine protease inhibitors |
| 10/04/2006 | EP1706400A1 Phenyl- 4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl -amine derivatives as igf-ir inhibitors |
| 10/04/2006 | EP1706399A1 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids |
| 10/04/2006 | EP1706398A1 Amino-benzazoles as p2y1 receptor inhibitors |
| 10/04/2006 | EP1706397A2 Novel amorphous form of omeprazole salts |
| 10/04/2006 | EP1706395A1 Thiophene and furan compounds |
| 10/04/2006 | EP1706393A1 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| 10/04/2006 | EP1706391A1 Modulators of glucocorticoid receptor, ap-1, and/or nf-&(k)beta activity and use thereof |
| 10/04/2006 | EP1706390A2 Isoxazole derivatives and their use as cyclooxygenase inhibitors |
| 10/04/2006 | EP1706389A1 3-hydroxymethyl-4-hydroxy-phenyl derivatives for the treatment of respiratory illnesses |
| 10/04/2006 | EP1706388A1 Therapeutic agents ii |
| 10/04/2006 | EP1706386A1 Bicyclic derivatives as ppar modulators |
| 10/04/2006 | EP1706385A1 Pyrazole derivatives as protein kinase modulators |
| 10/04/2006 | EP1706384A1 Therapeutic agents i |
| 10/04/2006 | EP1706380A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 10/04/2006 | EP1706379A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 10/04/2006 | EP1706375A2 Substituted n-aryl amidines as selective d1 dopamine receptor antagonists for the treatment of obesity and cns disorders |
| 10/04/2006 | EP1706372A1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists |
| 10/04/2006 | EP1706176A2 Frequency assisted transdermal agent delivery method and system |
| 10/04/2006 | EP1706147A2 COMBINATION THERAPY WITH 5-HT sb 1A /sb AND 5-HT sb 1B /sb RECEPTOR ANTAGONISTS |
| 10/04/2006 | EP1706146A1 Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 10/04/2006 | EP1706143A1 Cd40 antibody formulation and methods |
| 10/04/2006 | EP1706135A1 A treatment for necrotizing enterocolitis |
| 10/04/2006 | EP1706129A1 Drug therapy for celiac sprue |
| 10/04/2006 | EP1706122A2 Anti-viral pharmaceutical compositions |
| 10/04/2006 | EP1706121A1 Neutral endopeptidase (nep) and human soluble endopeptidase (hsep) inhibitors for prophylaxis and treatment of neurodegenerative disorders |
| 10/04/2006 | EP1706120A1 New derivatives of 6- 4 4 - 1 h - indole-2-sulphonyl)-pipera zin-1-carbonyl-phenyl pyradizin-3-one |
| 10/04/2006 | EP1706119A1 Novel pharmaceutical combinations containing scopine or tropic acid esters and egfr-kinase inhibitors |
| 10/04/2006 | EP1706118A1 New pharmaceutical compositions based on a scopineester and nicotinamide derivatives |
| 10/04/2006 | EP1706117A1 Method for treating erectile dysfunction |
| 10/04/2006 | EP1706116A1 Pharmaceutical compositions |
| 10/04/2006 | EP1706115A1 Controlled release pharmaceutical composition comprising an acid-insoluble and a bioadhesive polymer |
| 10/04/2006 | EP1706114A1 Chemical inhibitors of soluble adenylyl cyclase (sac) |
| 10/04/2006 | EP1706113A1 A process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2h-indol-2-one hydrochloride |
| 10/04/2006 | EP1706112A2 Methods of treating an inflammatory-related disease |
| 10/04/2006 | EP1706111A2 Compounds, compositions and methods |
| 10/04/2006 | EP1706110A1 Therapeutic use of quinonoid derivatives of cannabinoids |
| 10/04/2006 | EP1706109A1 Isoflavone therapy for treating urinary incontinence |
| 10/04/2006 | EP1706108A1 Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity |
| 10/04/2006 | EP1706107A1 Synergistic neuroprotective combinations of flavanols, hydroxystilbenes, flavanones, flavones, flavonols, proanthocyanidins and anthocyanidins |
| 10/04/2006 | EP1706106A1 Use of highly concentrated compositions of selected n-3 fatty acids for the treatment of central nervous system disturbances |
| 10/04/2006 | EP1706105A1 Method of treating type iii hypersensitive reaction-related diseases and conditions by using conjugated linoleic acid |
| 10/04/2006 | EP1706104A2 Methods for treating stress and affecting biological immune systems using a cysteamine compound |
| 10/04/2006 | EP1706102A1 Pharmaceutical formulations comprising metformin and a fibrate, and processes for obtaining them |
| 10/04/2006 | EP1706099A1 A medical product comprising tiotropium in a moisture-proof container |
| 10/04/2006 | EP1706098A2 Micellar systems useful for delivery of lipophilic or hydrophobic compounds |
| 10/04/2006 | EP1706097A2 Topically applied medicament for animals |
| 10/04/2006 | EP1706095A1 Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
| 10/04/2006 | EP1706092A2 Methods and compositions for the treatment of skin changes associated with aging and environmental damage |
| 10/04/2006 | EP1705990A1 Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof |
| 10/04/2006 | EP1705989A1 Substituted arylpyrazoles as parasiticidal agents |
| 10/04/2006 | EP1705988A1 Immunomodulatory compounds for the treatment of central nervous system disorders |
| 10/04/2006 | EP1628988B1 Novel 14 and 15 membered-ring compounds |
| 10/04/2006 | EP1626724A4 Method and kit for regulation of microvascular tone |
| 10/04/2006 | EP1569648A4 Prodrugs for use a ophthalmic agents |
| 10/04/2006 | EP1565471B1 Quinolinyl-pyrrolopyrazoles |